Quibim Raises €47.9M for AI-Powered Medical Imaging Expansion

Quibim, a Valencia-based HealthTech startup, has successfully raised €47.9 million in Series A financing to expand its operations into the U.S. market, aiming to enhance precision medicine through advanced imaging technology. Founded by Dr. Ángel Alberich-Bayarri, the company utilizes AI to analyze medical imaging data from MRI, CT, and PET scans, developing insights for conditions like cancer, neurology, and metabolic disorders. Quibim's innovations include creating 'digital twins' for improved patient monitoring and treatment testing, with its technology already deployed in over 170 organizations globally. This funding round was led by Asabys and Buenavista Equity Partners, alongside other strategic investors, which underscores the growing interest in AI-powered medical imaging solutions. The company is also in partnership with major pharmaceutical firms like Merck KGaA and Novartis to leverage its imaging biomarkers in clinical settings. With regulatory clearances in multiple regions, Quibim aims to revolutionize diagnostics and patient outcomes in healthcare.